Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · IEX Real-Time Price · USD
5.02
+0.01 (0.30%)
Jul 22, 2024, 11:32 AM EDT - Market open
Editas Medicine Employees
Editas Medicine had 265 employees as of December 31, 2023. The number of employees increased by 39 or 17.26% compared to the previous year.
Employees
265
Change (1Y)
39
Growth (1Y)
17.26%
Revenue / Employee
$261,913
Profits / Employee
-$626,917
Market Cap
414.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sonida Senior Living | 3,955 |
Health Catalyst | 1,300 |
Cerus | 637 |
Anika Therapeutics | 357 |
Esperion Therapeutics | 240 |
C4 Therapeutics | 145 |
Korro Bio | 102 |
Aura Biosciences | 89 |
EDIT News
- 5 weeks ago - Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress - GlobeNewsWire
- 5 weeks ago - Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress - GlobeNewsWire
- 2 months ago - Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June - GlobeNewsWire
- 2 months ago - Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire
- 2 months ago - Editas Medicine Announces First Quarter 2024 Results and Business Updates - GlobeNewsWire
- 2 months ago - Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events - GlobeNewsWire
- 2 months ago - Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration - GlobeNewsWire
- 3 months ago - Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire